SUMMARY Colloidal bismuth subcitrate (CBS; De-Nol) exhibits gastroprotective properties in experimental animals and enhances the healing of chronic gastroduodenal ulcers, but the mechanisms of these actions have not been entirely elucidated. The present study was designed to determine whether epidermal growth factor (EGF), which also has gastroprotective and ulcer healing properties, contributes to the action of De-Nol on the stomach in rats. It was found that De-Nol protects the gastric mucosa against ethanol damage and that this is accompanied by increased mucosal generation of prostaglandins (PG). Removal of the endogenous source of EGF (sialoadenectomy) did not significantly decrease the protective and PG stimulating effects of De-Nol. Pretreatment with exogenous EGF partially protected the stomach against ethanol injury, but did not influence the protective action of De-Nol in sialoadenectomised animals. De-Nol, like EGF given orally, enchanced the healing of chronic gastric and duodenal ulcers induced by serosal acetic acid. De-Nol was found to bind EGF in a pH-dependent manner and to accumulate it in ulcer area. Thus the peptide is available locally in high concentrations to accelerate the re-epithelialisation and tissue repair of the ulcerated mucosa. These ulcer healing effects of De-Nol were reduced by sialoadenectomy and restored in part by oral administration of EGF. We conclude that salivary glands in rats are not essential for the gastroprotection induced by De-Nol, but seem to play an important role in the ulcer healing action of this drug possibly via an EGF mediated mechanism.
EXPERIMENTS WITH ACUTE GASTRIC MUCOSAL LESIONS
Experiments with acute gastric lesions induced by absolute ethanol' were carried out in two series (series A and B) of rats. In the series A, the submandibular glands were removed bilaterally under ether anaesthesia one week earlier. In the series B, involving control rats with intact salivary glands, sham operation (longitudinal transection of the skin on the neck without removal of salivary glands) was done under similar conditions also one week before the experiment. The following experimental groups were included into the series A and B; group I with untreated stomach and without (20 rats) or with sialoadenectomy and without EGF (10 rats) or with EGF pretreatment (10 rats); group II with the stomach treated with 100% ethanol and with intact salivary glands (18 rats) or with sialoadenectomy and without EGF (20 rats) or with EGF pretreatment (20 rats) ; group III with the stomach treated with De-Nol alone, and intact salivary glands (10 rats) or with sialoadenectomy and without EGF (10 rats) or with EGF pretreatment (10 rats), group IV with stomach treated with the combination of De-Nol and 100% ethanol and with intact salivary glands (10 rats) or with sialoadenectomy and without EGF (10 rats) or with EGF pretreatment (10 rats); group V with stomach treated with the combination of 16,16 dm PGE2 and 100% ethanol and with intact salivary glands (eight rats) or with sialoadenectomy and without EGF (eight rats) or with EGF (eight rats) pretreatment; group VI with stomach treated with the combination of EGF and 100% ethanol and with intact salivary glands (10 rats) or with sialoadenectomy and without EGF (10 rats) or with EGF pretreatment (10 rats) .
The active ingredient of De-Nol formulation, colloidal bismuth subcitrate, was a gift from Dr D W R Hall, Department of Biological Research, Gistbrocades, Delft, The Netherlands. Colloidal bismuth subcitrate was dissolved in water and administered po in a dose of 40 mg/kg (in 1 ml volume) about 30 minutes before the start of the administration of absolute ethanol (1 ml) in rats of both series (A and B). For comparison, 16,16 dimethyl PGE2 (gift from Dr J Pike, The Upjohn Co, Kalamazoo, Michigan, USA) or EGF (gift from Dr H Gregory, ICI, England) were used po 30 minutes before absolute ethanol in a single dose of 100 [sg/kg (in 1 ml volume).
These doses were found previously to prevent the haemorrhagic lesions induced by absolute ethanol or acidified aspirin in the rat stomach.' 2 In addition, EGF was added for seven days to the drinking water in a dose of 30 [tg/kg/day in groups of rats from the A series starting with the first day after operation (sialoadenectomy). These animals received De-Nol or DMPGE2 30 minutes before absolute ethanol as in other groups. One hour after ethanol administration the animals were killed by a blow to the head, the stomach was removed and the area of gastric lesions was measured planimetrically (Morphomat, Carl Zeiss, Berlin, Germany).
In the tests with De-Nol alone and De-Nol plus absolute ethanol, done on intact and sialoadenectomised animals with and without pretreatment with EGF, the mucosal generation of PGE2 was determined. Immediately after killing the animals, the abdomen was opened and the stomach was clamped at the cardia and the pylorus. The stomach was washed of debris using 2 ml 0-02 M Tris buffer and then opened along the great curvature. A large (50 mg) biopsy of oxyntic mucosa was taken from the oxyntic gland area not involved in the macroscopic lesions, to determine the capability of the mucosa to generate PGE2 as previously described. '2All experiments were carried out on 24 h fasted rats.
EXPERIMENTS WITH CHRONIC GASTRIC AND DUODENAL ULCERATIONS
The following groups of rats with chronic gastric and duodenal ulcers induced by acetic acid and with the sialoadenectomy (series A) or with intact salivary glands (series B) were used; group 1 (30 rats) treated with De-Nol for seven or 14 days, group II treated with EGF (30 rats) for seven or 14 days, and group III control rats (30 rats) treated with vehicle only for seven or 14 days.
Chronic gastric and duodenal ulcers were produced using our modification'7 of the acetic acid method described by Okabe et al.' The animals were fasted for 24 h and under ether anaesthesia, their abdomen was opened and the stomach and duodenum exposed. A plastic mould of 4-2 mm diameter was applied tightly to the serosal surface of the anterior wall of the stomach just proximal to the antral gland area and then to the serosal surface of the duodenum about 5 mm beyond the pylorus. About 70 tl 100% acetic acid was poured through the mould on to the surface of the stomach and allowed to remain there for 20 s. Similarly, 70 t175% acetic acid was applied to the duodenum for 10 s. This method was found to cause an immediate necrosis of the entire thickness of the mucosa and submucosa directly under the area of the application of acetic acid. Gastric and duodenal ulcers were formed having an initial area of about 13 8 mm2 as described before. 17 Unlike the original technique of ulcerations described by Okabe et al'" our modification resulted in the formation of ulcers which did not penetrate into the surrounding organs and which healed completely within about two to three weeks. After application of acetic acid, the animals were allowed to recover from the anaesthesia and received only water on the day of operation (day 0). Then they were divided into various experimental groups and fed normal chow and water at libitum.
In rats with the submandibular glands removed or in sham operated animals acetic ulcers were induced and then the effects of De-Nol and EGF on the healing of these ulcers were tested during the period of seven to 14 Severe haemorrhagic lesions were found in the stomachs exposed to 100% ethanol in rats with intact and resected submandibulary glands. The mean lesion area in rats with intact glands averaged 78 (12) mm2 and that in sialoadenectomised rats was 52 (14) rats the ulcers were healed completely. The duodenal ulcers healed in all animals. In rats treated with DeNol, there was a significant decrease in the ulcer area seven days after ulcer induction in the stomach and duodenum; the ulcers were recorded in the stomach in three of 10 rats and in the duodenum in five of 10 animals, respectively. Similarly, EGF treatment resulted in a significant reduction in the ulcer area and the ulcer incidence both in the stomach and the duodenum.
In sialoadenectomised rats the area and the incidence of ulcers seven and 14 days after their induction, were significantly larger in the stomach but not in the duodenum than those in rats with intact salivary glands ( Table 2 ). De-Nol or EGF given alone to sialoadenectomised rats resulted in the significant reduction in mean ulcer area. When combined with EGF, De-Nol in sialoadenectomised rats decreased the area of ulcers to a greater extent than when given alone but this difference in the ulcer area was not statistically significant ( (Fig. 2) . Labelled EGF added in vitro to the solutions of De-Nol adjusted to various pH ranging from 1-5 to 8-0 was found to be coprecipitated with CBS in gradually increasing amounts as the pH of solution was reduced below pH 6-0. Significant binding of EGF to De-Nol occurred at pH 4-5 and it reached about 77% at pH 1-5 (Fig. 3) .
The distribution of the 1251-labelled EGF (measured at 180 min after introduction into the rat stomach) between the ulcer area and adjacent intact mucosa is shown in Figure 4 . There was a measurable amount of EGF bound to the intact mucosa both in the stomach and duodenum. The Figure 5 . The amounts of EGF in the area of gastric and duodenal ulcers were significantly higher than in the intact adjacent mucosa and this difference was further increased 180 minutes after pretreatment with De-Nol. The amounts of EGF in the duodenum within the ulcer area were significantly larger than in the stomach, in De-Nol treated and untreated rats. In the adjacent duodenal mucosa the amounts of EGF tended to be larger than in gastric mucosa but the difference was not statistically significant.
Discussion
This study provides evidence that (De-Nol) protects the gastric mucosa against the damage caused by absolute ethanol and enhances the healing rate of chronic gastric and duodenal ulcers, and that the ulcer healing effects of De-Nol may be mediated, at least in part, by epidermal growth factor (EGF).
Previous studies have shown that colloidal bismuth subcitrate exhibits gastroprotective action against itself does not stimulate the mucosal generation of PG,'2 although this does not exclude the possibility that the presence of EGF and normal mucosal growth and integrity are necessary conditions for adequate responsiveness of the mucosa to various agents.2' Such a notion would remain in agreement with the finding that sialoadenectomy increases the susceptibility of the mucosa to the damage by bile salts,22 possibly because of decrease in tissue growth and mucosal integrity, and that pentagastrin, which is a known trophic factor, reverses the susceptibility of the stomach to stress ulceration. 23 The major finding of this study is that colloidal bismuth enhances the healing rate or chronic gastric and duodenal ulcerations induced in rats by serosal application of acetic acid. Although De-Nol was reported to heal chronic gastroduodenal ulcerations in man' our study provides the first experimental evidence that De-Nol is effective in a fully standardised experimental model of chronic ulceration. The question remains as to the possible mechanism of the favourable influence of De-Nol on ulcer healing. As exogenous EGF in the same ulcer model also increased the ulcer healing'4 '5 we 
